As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

CX-2051 treatment demonstrated responses in patients with advanced, late-line colorectal cancer, according to interim data ...

The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met ...

Even after many cancer-free years, the fear of recurrence still lingers, and many long-term survivors struggle to keep those ...

The FDA approved Welireg for adult and pediatric patients 12 and older with locally advanced, unresectable or metastatic ...

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and ...

After walking alone in Chicago’s Cancer Survivor’s Walk, I found strength, healing and a renewed commitment to live fully and authentically — starting now.

Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate ...

Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for ...

I share how I survived multiple myeloma, painful spine fractures and years of recovery to reclaim my independence and ...